Evidence map›Paper›PMID 37959930›Full record

ArticlePolymers2023

Vancomycin-Loaded 3D-Printed Polylactic Acid-Hydroxyapatite Scaffolds for Bone Tissue Engineering.

Sara Pérez-Davila, Carmen Potel-Alvarellos, Raquel Carballo, Laura González-Rodríguez, Miriam López-Álvarez, Julia Serra, Patricia Díaz-Rodríguez, Mariana Landín, Pío González

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sara Pérez-DavilaCINTECX, Universidade de Vigo, Grupo Novos Materiais, 36310 Vigo, Spain.ORCID 0000-0001-7694-3847
Carmen Potel-AlvarellosGalicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, 36213 Vigo, Spain.ORCID 0000-0003-1565-1976
Raquel CarballoGalicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, 36213 Vigo, Spain.ORCID 0000-0003-0567-4779
Laura González-RodríguezCINTECX, Universidade de Vigo, Grupo Novos Materiais, 36310 Vigo, Spain.ORCID 0000-0002-6342-0526
Miriam López-ÁlvarezCINTECX, Universidade de Vigo, Grupo Novos Materiais, 36310 Vigo, Spain.ORCID 0000-0003-0118-7412
Julia SerraCINTECX, Universidade de Vigo, Grupo Novos Materiais, 36310 Vigo, Spain.
Patricia Díaz-RodríguezPharmacology, Pharmacy, and Pharmaceutical Technology Department, I+D Farma (GI-1645), Faculty of Pharmacy, Institute of Materials, iMATUS and Health Research Institute of Santiago de Compositela (IDIS), University of Santiago de Compostela, 15705 Santiago de Compostela, Spain.
Mariana LandínPharmacology, Pharmacy, and Pharmaceutical Technology Department, I+D Farma (GI-1645), Faculty of Pharmacy, Institute of Materials, iMATUS and Health Research Institute of Santiago de Compositela (IDIS), University of Santiago de Compostela, 15705 Santiago de Compostela, Spain.ORCID 0000-0002-2835-8958
Pío GonzálezCINTECX, Universidade de Vigo, Grupo Novos Materiais, 36310 Vigo, Spain.ORCID 0000-0002-7353-712X
Galicia Sur Biomedical Foundation · ESUniversidade de Santiago de Compostela · ESUniversity Hospital Complex Of Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The regeneration of bone remains one of the main challenges in the biomedical field, with the need to provide more personalized and multifunctional solutions. The other persistent challenge is related to the local prevention of infections after implantation surgery. To fulfill the first one and provide customized scaffolds with complex geometries, 3D printing is being investigated, with polylactic acid (PLA) as the biomaterial mostly used, given its thermoplastic properties. The 3D printing of PLA in combination with hydroxyapatite (HA) is also under research, to mimic the native mechanical and biological properties, providing more functional scaffolds. Finally, to fulfill the second one, antibacterial drugs locally incorporated into biodegradable scaffolds are also under investigation. This work aims to develop vancomycin-loaded 3D-printed PLA-HA scaffolds offering a dual functionality: local prevention of infections and personalized biodegradable scaffolds with osseointegrative properties. For this, the antibacterial drug vancomycin was incorporated into 3D-printed PLA-HA scaffolds using three loading methodologies: (1) dip coating, (2) drop coating, and (3) direct incorporation in the 3D printing with PLA and HA. A systematic characterization was performed, including release kinetics,

Indexed as

3D printingantibacterialbiocompatibilityhydroxyapatitepolylactic acidvancomycin

Identifiers

PMID37959930
PMCPMC10648244
OpenAlexW4388093904

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.